I believe "bench-level" refers to testing confined to a 'laboratory'...
agree...they should have re-iterated the 300% increase factor... also agree about the lack of PPS movement...guess it will take more convincing for folks to jump onboard...understandable to a degree...their have been way2many false-starts & un-kept promises made in the past by other companies in Lipid Trigger tech.
Will likely take a contract by 3rd-party to prove this out , as far as the investment community is concerned. If they succeed however, I could imagine institutional investors getting into this. Lipid Trigger tech is a bonanza to anyone that can make it a reality.